Participant flow44

How many started, completed or left each group, period by period.

1 to 20 of 44

Period	Milestone	Group	Participants
Treatment Period 1	STARTED	LY2495655	102
Treatment Period 1	STARTED	Placebo	99
Treatment Period 1	Received at Least 1 Dose of Study Drug	LY2495655	102
Treatment Period 1	Received at Least 1 Dose of Study Drug	Placebo	99
Treatment Period 1	COMPLETED	LY2495655	102
Treatment Period 1	COMPLETED	Placebo	98
Treatment Period 1	NOT COMPLETED	LY2495655	0
Treatment Period 1	NOT COMPLETED	Placebo	1
Treatment Period 2	STARTED	LY2495655	102
Treatment Period 2	STARTED	Placebo	98
Treatment Period 2	COMPLETED	LY2495655	100
Treatment Period 2	COMPLETED	Placebo	96
Treatment Period 2	NOT COMPLETED	LY2495655	2
Treatment Period 2	NOT COMPLETED	Placebo	2
Treatment Period 3	STARTED	LY2495655	100
Treatment Period 3	STARTED	Placebo	96
Treatment Period 3	COMPLETED	LY2495655	95
Treatment Period 3	COMPLETED	Placebo	91
Treatment Period 3	NOT COMPLETED	LY2495655	5
Treatment Period 3	NOT COMPLETED	Placebo	5

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01604408/flow